IDEAS home Printed from https://ideas.repec.org/a/ucp/jpolec/doi10.1086-730383.html

Funding of Clinical Trials and Reported Drug Efficacy

Author

Listed:
  • Tamar Oostrom

Abstract

This paper estimates the effect of financial sponsorship of clinical trials on reported drug efficacy, leveraging the insight that the exact same pairs of drugs are often compared in different trials conducted by parties with different financial interests. I assemble new psychiatric trial data to estimate that a drug appears substantially more effective when the trial is sponsored by that drug’s manufacturer, compared with the same drug tested against the same combination of drugs but without sponsorship. This difference is not explained by observable characteristics, but publication bias is important. Preregistration may be effective in overcoming this bias.

Suggested Citation

  • Tamar Oostrom, 2024. "Funding of Clinical Trials and Reported Drug Efficacy," Journal of Political Economy, University of Chicago Press, vol. 132(10), pages 3298-3333.
    • Handle: RePEc:ucp:jpolec:doi:10.1086/730383
    DOI: 10.1086/730383
    as

    Download full text from publisher

    File URL: http://dx.doi.org/10.1086/730383
    Download Restriction: Access to the online full text or PDF requires a subscription.
    File URL: http://dx.doi.org/10.1086/730383
    Download Restriction: Access to the online full text or PDF requires a subscription.
    File URL: https://libkey.io/10.1086/730383?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    References listed on IDEAS

    as
    1. DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
    2. Hunt Allcott, 2015. "Site Selection Bias in Program Evaluation," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(3), pages 1117-1165.
    3. Michael Sinkinson & Amanda Starc, 2019. "Ask Your Doctor? Direct-to-Consumer Advertising of Pharmaceuticals," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 86(2), pages 836-881.
    4. Omar Al‐Ubaydli & John A. List & Dana Suskind, 2020. "2017 Klein Lecture: The Science Of Using Science: Toward An Understanding Of The Threats To Scalability," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 61(4), pages 1387-1409, November.
    5. Camerer, Colin & Dreber, Anna & Forsell, Eskil & Ho, Teck-Hua & Huber, Jurgen & Johannesson, Magnus & Kirchler, Michael & Almenberg, Johan & Altmejd, Adam & Chan, Taizan & Heikensten, Emma & Holzmeist, 2016. "Evaluating replicability of laboratory experiments in Economics," MPRA Paper 75461, University Library of Munich, Germany.
    6. Eva Vivalt, 2020. "How Much Can We Generalize From Impact Evaluations?," Journal of the European Economic Association, European Economic Association, vol. 18(6), pages 3045-3089.
    7. Andrew T. Ching & Robert Clark & Ignatius Horstmann & Hyunwoo Lim, 2016. "The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs," Marketing Science, INFORMS, vol. 35(1), pages 158-181, January.
    8. Bradley T. Shapiro, 2022. "Promoting Wellness or Waste? Evidence from Antidepressant Advertising," American Economic Journal: Microeconomics, American Economic Association, vol. 14(2), pages 439-477, May.
    9. Eric Budish & Benjamin N. Roin & Heidi Williams, 2015. "Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials," American Economic Review, American Economic Association, vol. 105(7), pages 2044-2085, July.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Bernheim, Emmanuelle, 2025. "Rights against Abolition: how Law and Rights perpetuate Psychiatric Coercition," Social Science & Medicine, Elsevier, vol. 384(C).
    2. Barrios, John & Lancieri, Filippo Maria & Levy, Joshua & Singh, Shashank & Valletti, Tommaso M. & Zingales, Luigi, 2024. "The conflict-of-interest discount in the marketplace of ideas," Working Papers 348, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Omar Al-Ubaydli & John List & Claire Mackevicius & Min Sok Lee & Dana Suskind, 2019. "How Can Experiments Play a Greater Role in Public Policy? 12 Proposals from an Economic Model of Scaling," Artefactual Field Experiments 00679, The Field Experiments Website.
    2. Yin, Nina, 2023. "Pharmaceuticals, incremental innovation and market exclusivity," International Journal of Industrial Organization, Elsevier, vol. 87(C).
    3. Pierre Dubois & Ariel Pakes, 2026. "Pharmaceutical Advertising in Dynamic Equilibrium," Working Papers hal-05573625, HAL.
    4. repec:osf:osfxxx:nwp8k_v1 is not listed on IDEAS
    5. Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).
    6. Stefano DellaVigna & Elizabeth Linos, 2022. "RCTs to Scale: Comprehensive Evidence From Two Nudge Units," Econometrica, Econometric Society, vol. 90(1), pages 81-116, January.
    7. Brandyn F. Churchill & Laura E. Henkhaus & Emily C. Lawler, 2025. "Effect of vaccine recommendations on consumer and firm behavior," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 44(1), pages 125-150, January.
    8. Castaing, Pauline & Gazeaud, Jules, 2025. "Do index insurance programs live up to their promises? Aggregating evidence from multiple experiments," Journal of Development Economics, Elsevier, vol. 175(C).
    9. Werthschulte, Madeline, 2023. "Present focus and billing systems: Testing ‘pay-as-you-go’ vs. ‘pay-later’," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 108-121.
    10. Rose, Julian & Neubauer, Florian & Ankel-Peters, Jörg, 2024. "Long-Term Effects of the Targeting the Ultra-Poor Program - A Reproducibility and Replicability Assessment of Banerjee et al. (2021)," I4R Discussion Paper Series 142, The Institute for Replication (I4R).
    11. Cristina Corduneanu-Huci & Michael T. Dorsch & Paul Maarek, 2017. "Learning to constrain: Political competition and randomized controlled trials in development," Thema Working Papers 2017-24, THEMA (Théorie Economique, Modélisation et Applications), CY Cergy-Paris University, ESSEC and CNRS.
    12. Andor, Mark A. & Gerster, Andreas & Peters, Jörg, 2022. "Information campaigns for residential energy conservation," European Economic Review, Elsevier, vol. 144(C).
    13. Masselus, Lise & Petrik, Christina & Ankel-Peters, Jörg, 2024. "Lost in the design space? Construct validity in the microfinance literature," Ruhr Economic Papers 1097, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    14. Faraz Usmani & Marc Jeuland & Subhrendu K. Pattanayak, 2024. "NGOs and the Effectiveness of Interventions," The Review of Economics and Statistics, MIT Press, vol. 106(6), pages 1690-1708, November.
    15. Byrski, Dennis & Wang, Lucy Xiaolu, 2025. "Marketing authorization and strategic patenting: Evidence from pharmaceuticals," Journal of Public Economics, Elsevier, vol. 247(C).
    16. Henry Grabowski & Carlos Brain & Anna Taub & Rahul Guha, 2017. "Pharmaceutical Patent Challenges: Company Strategies and Litigation Outcomes," American Journal of Health Economics, MIT Press, vol. 3(1), pages 33-59, Winter.
    17. Leila Agha & Soomi Kim & Danielle Li, 2022. "Insurance Design and Pharmaceutical Innovation," American Economic Review: Insights, American Economic Association, vol. 4(2), pages 191-208, June.
    18. Corduneanu-Huci, Cristina & Dorsch, Michael T. & Maarek, Paul, 2021. "The politics of experimentation: Political competition and randomized controlled trials," Journal of Comparative Economics, Elsevier, vol. 49(1), pages 1-21.
    19. Riedmiller, Sebastian & Sutter, Matthias & Tonke, Sebastian, 2025. "Designing Effective Interventions," IZA Discussion Papers 18273, IZA Network @ LISER.
    20. Anita Rao, 2020. "Strategic Research and Development Investment Decisions in the Pharmaceutical Industry," Marketing Science, INFORMS, vol. 39(3), pages 564-586, May.
    21. Zentner, Alejandro & Holz, Justin, 2025. "Frictions in recovering unclaimed property: Evidence from a large-scale natural field experiment," Journal of Public Economics, Elsevier, vol. 249(C).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ucp:jpolec:doi:10.1086/730383. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Journals Division (email available below). General contact details of provider: https://www.journals.uchicago.edu/JPE .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.